Table 3.

Adverse events during HAIC and VAX-NK/HCC therapy.

A. Hematologic adverse events
Adverse events	Any Gradenumber (%)	Grade ≥ 3number (%)
Anemia	5 (45.5)	1 (9.1)
Hyperkalemia	4 (36.4)	1 (9.1)
Neutropenia	2 (18.2)	2 (18.2)
Thrombocytopenia	1 (9.1)	0 (0)
Increased creatinine	1 (9.1)	0 (0)
Hypomagnesemia	1 (9.1)	0 (0)
B. Non-hematologic adverse events
Adverse events	Any Gradenumber (%)	Grade ≥ 3number (%)
Nausea	7 (63.6)	0 (0)
Fatigue	3 (27.3)	2 (18.2)
Rhinorrhea	2 (18.2)	0 (0)
Ascites	1 (9.1)	0 (0)
Pain	1 (9.1)	0 (0)
Headache	1 (9.1)	0 (0)
Myalgia	1 (9.1)	0 (0)
Vomiting	1 (9.1)	0 (0)
Dizziness	1 (9.1)	0 (0)

HAIC, hepatic arterial infusion chemotherapy; HCC, hepatocellular carcinoma; NK, natural killer.